ImmunoCellular Therapeutics, Ltd. (IMUC.OB) Allowed New Patent for its Antibody
One company that has started to make a name for its self in the medical and financial community is ImmunoCellular Therapeutics. Located in Los Angeles, California, ImmunoCellular is a clinical stage company that is developing immune-based therapies for the treatment of brain and other cancers. Today, the young company took a major step towards enhancing its future with the announcement they have received a notice of allowance for a new patent for its antibody ICT-69. The ICT-69 is a revolutionary antibody because it targets multiple myeloma and ovarian cancers. The ICT-69 has been successful in that it has demonstrated high…